BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10707794)

  • 1. The ATM gene in the pathogenesis of mantle-cell lymphoma.
    Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
    Ann Oncol; 2000; 11 Suppl 1():127-30. PubMed ID: 10707794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma.
    Stilgenbauer S; Winkler D; Ott G; Schaffner C; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
    Blood; 1999 Nov; 94(9):3262-4. PubMed ID: 10556216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
    Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
    Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.
    Stilgenbauer S; Liebisch P; James MR; Schröder M; Schlegelberger B; Fischer K; Bentz M; Lichter P; Döhner H
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11837-41. PubMed ID: 8876224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.
    Filippi AR; Franco P; Galliano M; Ricardi U
    Radiat Oncol; 2006 Sep; 1():35. PubMed ID: 16956411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
    Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
    Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
    Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Milani R; Bardi A; Minotto C; Agostini P; De Angeli C; Narducci MG; Sabbioni S; Russo G; Negrini M; Castoldi G
    J Clin Oncol; 2000 Jul; 18(13):2607-14. PubMed ID: 10893293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
    Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
    Bentz M; Plesch A; Bullinger L; Stilgenbauer S; Ott G; Müller-Hermelink HK; Baudis M; Barth TF; Möller P; Lichter P; Döhner H
    Genes Chromosomes Cancer; 2000 Mar; 27(3):285-94. PubMed ID: 10679918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L
    Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of genetic changes in MCL by interphase FISH on tissue sections.
    Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
    Leuk Lymphoma; 2007 Jul; 48(7):1344-52. PubMed ID: 17613764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of ATM deletions in 16 cases of splenic marginal-zone B-cell lymphoma (SMZBCL).
    Salido M; Astier L; Puigdecanet E; Espinet B; Florensa L; Solé F
    Haematologica; 2003 Nov; 88(11):ELT33. PubMed ID: 14607769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
    Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
    M'kacher R; Bennaceur A; Farace F; Laugé A; Plassa LF; Wittmer E; Dossou J; Violot D; Deutsch E; Bourhis J; Stoppa-Lyonnet D; Ribrag V; Carde P; Parmentier C; Bernheim A; Turhan AG
    Oncogene; 2003 Sep; 22(39):7905-12. PubMed ID: 12970738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
    González MB; Hernández JM; García JL; Lumbreras E; Castellanos M; Hernández JM; Fernández-Calvo J; Gutiérrez NC; San Miguel JF
    Haematologica; 2004 Oct; 89(10):1213-8. PubMed ID: 15477206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma: a biological and therapeutic paradigm.
    Decaudin D
    Leuk Lymphoma; 2002 Apr; 43(4):773-81. PubMed ID: 12153164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.